Filter Results:
(1,672)
Show Results For
- All HBS Web
(1,672)
- People (4)
- News (502)
- Research (918)
- Events (5)
- Multimedia (22)
- Faculty Publications (489)
Show Results For
- All HBS Web
(1,672)
- People (4)
- News (502)
- Research (918)
- Events (5)
- Multimedia (22)
- Faculty Publications (489)
- Web
Placement - Doctoral
Business Economics, 2022 Placement: Australian National University Dissertation: Essays in Applied Microeconomics Advisors: David Laibson (Chair), Andrei Shleifer , Edward Glaeser , and Gabriel Kreindler Frank Pinter Business Economics,... View Details
- January 2015 (Revised July 2019)
- Case
CVS Health: Promoting Drug Adherence
Email mking@hbs.edu for a courtesy copy.
The case describes a program that CVS Health recently implemented to improve medication adherence, an important problem from a societal, public policy, and firm... View Details
The case describes a program that CVS Health recently implemented to improve medication adherence, an important problem from a societal, public policy, and firm... View Details
Keywords: Medication Adherence; Affordable Care Act (ACA); Marketing Strategy; Communication Strategy; Customer Value and Value Chain; Decisions; Health Care and Treatment; Goals and Objectives; Resource Allocation; Marketing Communications; Consumer Behavior; Measurement and Metrics; Service Delivery; Behavior; Motivation and Incentives; Social Issues; Information Technology; Value Creation; Health Industry; Health Industry; Health Industry; Health Industry; Health Industry; United States
John, Leslie, John Quelch, and Robert Huckman. "CVS Health: Promoting Drug Adherence." Harvard Business School Case 515-010, January 2015. (Revised July 2019.) (Email mking@hbs.edu for a courtesy copy.)
Alvin E. Roth
Al Roth is the George Gund Professor of Economics and Business Administration in the Department of Economics at Harvard University, and in the Harvard Business School. His research, teaching, and consulting interests are in game theory, experimental economics, and... View Details
- April 2017
- Case
Global Leadership in a Dynamic and Evolving Region: Molinas @ The Coca-Cola Company (A)
By: Tsedal Neeley and Esel Çekin
Galya Frayman Molinas, President of Coca-Cola's Turkish business and a 20-year company veteran, is unexpectedly asked to take the helm of a newly expanded territory with operations across eight additional countries in Central Asia: Armenia, Azerbaijan, Georgia,... View Details
Keywords: Functions; Structure; Centralization; Decentralization; Diversity; Country Of Origin Effects; Global Contextual Intelligence; Leading Change; Crisis Management; Organizational Structure; Experience and Expertise; Situation or Environment; Central Asia; Turkey
Neeley, Tsedal, and Esel Çekin. "Global Leadership in a Dynamic and Evolving Region: Molinas @ The Coca-Cola Company (A)." Harvard Business School Case 417-068, April 2017.
- Research Summary
Current Research
By: Leslie K. John
Professor John is a behavioral scientist who uses both laboratory and field experiments to investigate questions that are at the intersection of marketing, organizational behavior, and public policy.
Professor John’s work has been published in leading... View Details
- November 2007
- Class Lecture
The Baby Business (FSS)
By: Debora L. Spar
In vitro fertilization and genetic screening are possible with the advent of biotechnology. International adoptions, surrogacy, and other approaches to family planning are on the rise. But few rules govern these measures, medical costs can be prohibitive, and... View Details
Keywords: Governing Rules, Regulations, and Reforms; Policy; Demand and Consumers; Business and Government Relations; Business and Stakeholder Relations; Genetics; Societal Protocols; Commercialization; Health Industry; Health Industry
Spar, Debora L. "The Baby Business (FSS)." Harvard Business School Class Lecture 708-701, November 2007.
- Research Summary
AIDS in Africa: Life, Death and Property Rights
By: Debora L. Spar
In the final years of the twentieth century, the world was hit by a plague of epidemic proportions--the plague of AIDS, a life-threatening disease that remained stubbornly immune to any cure or vaccine. In the developed nations of the West, AIDS was slowly brought... View Details
- 28 Oct 2011
- Working Paper Summaries
Fairness, Efficiency, and Flexibility in Organ Allocation for Kidney Transplantation
- October 2023 (Revised March 2024)
- Case
KOKO Networks: Bridging Energy Transition and Affordability with Carbon Financing
By: George Serafeim, Siko Sikochi and Namrata Arora
The problem was massive: two million hectares of African forests were lost annually to charcoal production for cooking, an area equivalent to 13 times Greater London, resulting in one billion tons of carbon emissions yearly. At the same time, an estimated 700,000... View Details
Keywords: Clean Tech; Digital; Carbon Credits; Carbon Offsetting; Climate Change; Entrepreneurship; Energy Sources; Environmental Sustainability; Health; Market Design; Business Startups; Transition; Environmental Regulation; Policy; Energy Industry; Consumer Products Industry; Africa; Kenya; Rwanda
Serafeim, George, Siko Sikochi, and Namrata Arora. "KOKO Networks: Bridging Energy Transition and Affordability with Carbon Financing." Harvard Business School Case 124-022, October 2023. (Revised March 2024.)
- January 2002
- Case
Price-Fixing Vignettes
By: Guhan Subramanian and Michelle Kalka
This case escribes the antitrust prosecutions in the United States and abroad of the international bulk vitamins cartel. Both the civil and criminal fines were historically high, and it was the first time the United States prosecuted foreign nationals for U.S. criminal... View Details
Keywords: Price; Lawsuits and Litigation; Governance Compliance; Auctions; Laws and Statutes; Monopoly; Globalized Markets and Industries; Health Industry; Health Industry; United States
Subramanian, Guhan, and Michelle Kalka. "Price-Fixing Vignettes." Harvard Business School Case 902-068, January 2002.
- Web
Accounting & Management - Faculty & Research
(2013-2023)." Harvard Business School Case 125-088, May 2025. Humana Commits to Value-Based Care By: V.G. Narayanan , Henry Eyring and David Lane May 2025 (Revised May 2025) | Case | Faculty Research In late 2023, CEO Bruce Broussard reviewed View Details
- 25 Apr 2000
- Research & Ideas
Adjusting the Fit for Government
pointed out. Panelist Dean Donovan, managing partner of Bain & Company in South Africa, said the imperatives for African governments are many, and are all intertwined. The key underpinnings include a health policy that deals with... View Details
Keywords: by Martha Lagace
- December 2016
- Article
Selective Regulator Decoupling and Organizations' Strategic Responses
By: Jonas Heese, Ranjani Krishnan and Frank Moers
Organizations often respond to institutional pressures by symbolically adopting policies and procedures but decoupling them from actual practice. Literature has examined why organizations decouple from regulatory pressures. In this study, we argue that decoupling... View Details
Keywords: Regulator Leniency; Beneficence; Mispricing; Upcoding; Nonprofit Organizations; Health Care and Treatment; Revenue; Health Industry
Heese, Jonas, Ranjani Krishnan, and Frank Moers. "Selective Regulator Decoupling and Organizations' Strategic Responses." Academy of Management Journal 59, no. 6 (December 2016). (Selected for Best Paper Proceedings of the 2015 Academy of Management Annual Meeting. Winner of the Healthcare Management Division of the Academy of Management 2015 Best Paper Award.)
- 22 Apr 2016
- HBS Seminar
Dr. Milt McColl, MD, Gauss Surgical, CEO
- 16 Dec 2014
- First Look
First Look: December 16
challenges facing Dr. John Noseworthy, president and CEO, in implementing a long-term strategy for the growth of the Mayo Clinic-a leading academic medical center with a reputation for excellence in tertiary and quaternary health care.... View Details
Keywords: Sean Silverthorne
- Article
Internal Deadlines, Drug Approvals, and Safety Problems
By: Lauren Cohen, Umit Gurun and Danielle Li
Absent explicit quotas, incentives, reporting, or fiscal year-end motives, drug approvals around the world surge in December, at month-ends, and before respective major national holidays. Drugs approved before these informal deadlines are associated with significantly... View Details
Keywords: Health; Economics; Government and Politics; Innovation and Invention; Research; Science; Health Industry; Health Industry; Health Industry
Cohen, Lauren, Umit Gurun, and Danielle Li. "Internal Deadlines, Drug Approvals, and Safety Problems." American Economic Review: Insights 3, no. 1 (March 2021): 67–82.
- 05 Mar 2007
- Research & Ideas
Risky Business? Protecting Foreign Investments
Foreign investment in developing countries has always involved an element of risk. Just ask Verizon Communications, which could lose hundreds of millions of dollars in Venezuela should President Hugo Chávez follow through with plans announced in January to View Details
- 19 Aug 2020
- News